Hoth Therapeutics (HOTH) announced that it has received notification from the Listing Qualifications Department of The Nasdaq Stock Market that the Company has regained compliance with Nasdaq’s minimum bid price requirement under Listing Rule 5550. The Company received written notification from Nasdaq on January 23, 2025, stating that because the Company’s common stock had a closing bid price at or above $1.00 per share for 10 consecutive business days, from January 7 to January 22, the Company has regained compliance with Listing Rule 5550, and this matter is now closed.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOTH:
- Hoth Therapeutics expands IP portfolio with patent application acquisitions
- Biotech Alert: Searches spiking for these stocks today
- 3 Penny Stocks to Watch Now, 1/9/25
- Hoth Therapeutics responds to market rumors, says no plans for offering
- Hoth Therapeutics affirms no plans for public, private offering at this time
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue